{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:13:51Z","timestamp":1764260031030},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2018,6,21]]},"DOI":"10.18632\/aging.101487","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T20:37:15Z","timestamp":1529613435000},"page":"1506-1522","source":"Crossref","is-referenced-by-count":14,"title":["Fanconi Anemia complementation group C protein in metabolic disorders"],"prefix":"10.18632","volume":"10","author":[{"given":"Manoj","family":"Nepal","sequence":"first","affiliation":[{"name":"University of Hawaii Cancer Center, Honolulu, HI 96813, USA"},{"name":"Graduate Program of Molecular Biosciences and Bioengineering, University of Hawaii, Honolulu, HI 96822, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Ma","sequence":"additional","affiliation":[{"name":"University of Hawaii Cancer Center, Honolulu, HI 96813, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxiang","family":"Xie","sequence":"additional","affiliation":[{"name":"University of Hawaii Cancer Center, Honolulu, HI 96813, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jia","sequence":"additional","affiliation":[{"name":"University of Hawaii Cancer Center, Honolulu, HI 96813, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiwen","family":"Fei","sequence":"additional","affiliation":[{"name":"University of Hawaii Cancer Center, Honolulu, HI 96813, USA"},{"name":"Graduate Program of Molecular Biosciences and Bioengineering, University of Hawaii, Honolulu, HI 96822, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,6,21]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism.","volume":"2","author":"Thompson","year":"2016","journal-title":"Cell Metab"},{"key":"2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes.","volume":"1","author":"Mootha","year":"2011","journal-title":"Nat Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes.","volume":"11","author":"Hotamisligil","year":"2005","journal-title":"J Clin Invest"},{"key":"4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1172\/JCI29024","article-title":"Insulin resistance and atherosclerosis.","volume":"11","author":"Semenkovich","year":"2006","journal-title":"J Clin Invest"},{"key":"5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3324\/haematol.2015.136739","article-title":"The European Hematology Association Roadmap for European Hematology Research: a consensus document.","volume":"10","author":"Jaffredo","year":"2016","journal-title":"Haematologica"},{"key":"6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.tig.2017.11.006","article-title":"Multifaceted Fanconi Anemia Signaling.","volume":"3","author":"Fei","year":"2018","journal-title":"Trends Genet"},{"key":"7","doi-asserted-by":"publisher","first-page":"E1804","DOI":"10.3390\/ijms18081804","article-title":"FANCD2 and DNA Damage.","volume":"1","author":"Fei","year":"2017","journal-title":"Int J Mol Sci"},{"key":"8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.trecan.2017.10.005","article-title":"Fanconi Anemia Signaling and Cancer.","volume":"3","author":"Fei","year":"2017","journal-title":"Trends Cancer"},{"key":"9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/2159-8290.CD-14-1156","article-title":"Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.","volume":"5","author":"Greenberg","year":"2015","journal-title":"Cancer Discov"},{"key":"10","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1016\/j.jmb.2015.08.004","article-title":"Analysis of a FANCE splice isoform in regard to dna repair.","volume":"42","author":"Durocher","year":"2015","journal-title":"J Mol Biol"},{"key":"11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gde.2015.07.002","article-title":"Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics.","volume":"3","author":"Surrall\u00e9s","year":"2015","journal-title":"Curr Opin Genet Dev"},{"key":"12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature11863","article-title":"Fanconi anaemia and the repair of Watson and Crick DNA crosslinks.","volume":"49","author":"Smogorzewska","year":"2013","journal-title":"Nature"},{"key":"13","unstructured":"National Cancer Institute Cisplatin http:\/\/wwwcancergov\/cancertopics\/druginfo\/cisplatin. 2014."},{"key":"14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mrfmmm.2009.05.006","article-title":"Genotype-phenotype correlations in Fanconi anemia.","volume":"66","author":"Schindler","year":"2009","journal-title":"Mutat Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1021\/acs.jproteome.6b00076","article-title":"Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway.","volume":"1","author":"Fei","year":"2016","journal-title":"J Proteome Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"20396","DOI":"10.18632\/oncotarget.4056","article-title":"Mutated Fanconi anemia pathway in non-Fanconi anemia cancers.","volume":"6","author":"Fei","year":"2015","journal-title":"Oncotarget"},{"key":"17","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1172\/JCI40908","article-title":"FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth.","volume":"12","author":"Fei","year":"2010","journal-title":"J Clin Invest"},{"key":"18","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1089\/ars.2011.4417","article-title":"Fanconi anemia links reactive oxygen species to insulin resistance and obesity.","volume":"1","author":"Pang","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13058-018-0980-4","article-title":"NDRG1 regulates neutral         lipid metabolism in breast cancer cells.","volume":"2","author":"Conklin","year":"2018","journal-title":"Breast Cancer Res"},{"key":"20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.4161\/cc.23755","article-title":"Recruitment of DNA polymerase eta by FANCD2 in the early response to DNA damage.","volume":"1","author":"Fei","year":"2013","journal-title":"Cell Cycle"},{"key":"21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1089\/omi.2010.0121","article-title":"Metabolic signatures in apoptotic human cancer cell lines.","volume":"1","author":"Adamski","year":"2011","journal-title":"OMICS"},{"key":"22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15430\/JCP.2017.22.1.1","article-title":"Anti-cancer Mechanism of Docosahexaenoic Acid in Pancreatic Carcinogenesis: A Mini-review.","volume":"2","author":"Kim","year":"2017","journal-title":"J Cancer Prev"},{"key":"23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-1-4419-6741-1_13","article-title":"Cancer treatment strategies targeting sphingolipid metabolism.","volume":"68","author":"Saba","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/CAD.0000000000000038","article-title":"L-Methionine inhibits growth of human pancreatic cancer cells.","volume":"2","author":"dos Santos","year":"2014","journal-title":"Anticancer Drugs"},{"key":"25","doi-asserted-by":"publisher","first-page":"e49062","DOI":"10.1371\/journal.pone.0049062","article-title":"L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro.","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"26","first-page":"1095","article-title":"Analogs of L-aspartic acid in chemotherapy for cancer.","volume":"6","author":"Cooney","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jsps.2012.12.007","article-title":"Glutamic acid as anticancer agent: an overview.","volume":"2","author":"Nagarajan","year":"2013","journal-title":"Saudi Pharm J"},{"key":"28","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.","volume":"37","author":"Damian","year":"2015","journal-title":"N Engl J Med"},{"key":"29","first-page":"95","article-title":"Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study.","volume":"3","author":"Maria","year":"2012","journal-title":"Anticancer Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/srep00134","article-title":"The metabolic footprint of aging in mice.","volume":"1","author":"Auwerx","year":"2011","journal-title":"Sci Rep"},{"key":"31","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4049\/jimmunol.164.2.1013","article-title":"Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock.","volume":"16","author":"Szab\u00f3","year":"2000","journal-title":"J Immunol"},{"key":"32","first-page":"299","article-title":"Anti-inflammatory and analgesic properties of four amino-acids.","volume":"2","author":"Khanna","year":"1984","journal-title":"Indian J Physiol Pharmacol"},{"key":"33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1096\/fj.00-0299com","article-title":"Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death.","volume":"1","author":"Szab\u00f3","year":"2001","journal-title":"FASEB J"},{"key":"34","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2353\/ajpath.2008.071009","article-title":"L-arginine decreases inflammation and modulates the nuclear factor-kappaB\/matrix metalloproteinase cascade in mdx muscle fibers.","volume":"17","author":"Mornet","year":"2008","journal-title":"Am J Pathol"},{"key":"35","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1016\/j.celrep.2017.08.093","article-title":"Fumarate Hydratase Deletion in Pancreatic \u03b2 Cells Leads to Progressive Diabetes.","volume":"2","author":"Do","year":"2017","journal-title":"Cell Reports"},{"key":"36","first-page":"303","article-title":"The role of collagen crosslinks in ageing and diabetes - the good, the bad, and the ugly.","volume":"4","author":"Gautieri","year":"2014","journal-title":"Muscles Ligaments Tendons J"},{"key":"37","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.2337\/dc08-2075","article-title":"Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women.","volume":"3","author":"Kraus","year":"2009","journal-title":"Diabetes Care"},{"key":"38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jacc.2008.03.043","article-title":"Application of metabolomics to cardiovascular biomarker and pathway discovery.","volume":"5","author":"Gerszten","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/cc.4.1.1358","article-title":"Advances in the DNA damage response network of Fanconi anemia and BRCA proteins, FAAP95 replaces BRCA2 as the true FANCB protein","volume":"4","author":"Wang","year":"2005","journal-title":"Cell Cycle"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Warburg O. 1956. On the origin of cancer cells. pp. 309-314.","DOI":"10.1126\/science.123.3191.309"},{"key":"41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12967-015-0576-z","article-title":"Metabolic signatures differentiate ovarian from colon cancer cell lines.","volume":"1","author":"Rafii","year":"2015","journal-title":"J Transl Med"},{"key":"42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0014-4827(03)00261-1","article-title":"Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport.","volume":"28","author":"Huber","year":"2003","journal-title":"Exp Cell Res"},{"key":"43","first-page":"3737","article-title":"A novel BTB\/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.","volume":"9","author":"Zelent","year":"1999","journal-title":"Blood"},{"key":"44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","article-title":"The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.","volume":"1","author":"Bishop","year":"2012","journal-title":"Cell Metab"},{"key":"45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/intimm\/dxq455","article-title":"IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid.","volume":"2","author":"Inoue","year":"2011","journal-title":"Int Immunol"},{"key":"46","unstructured":"Hotamisligil GkS. 2006. Inflammation and metabolic disorders. Nature Publishing Group), pp. 860-867."},{"key":"47","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1172\/JCI40908","article-title":"FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth.","volume":"12","author":"Fei","year":"2010","journal-title":"J Clin Invest"},{"key":"48","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.18632\/oncotarget.1796","article-title":"Basal level of FANCD2 monoubiquitination is required for the maintenance of a sufficient number of licensed-replication origins to fire at a normal rate.","volume":"5","author":"Fei","year":"2014","journal-title":"Oncotarget"},{"key":"49","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1021\/pr500443c","article-title":"Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.","volume":"1","author":"Jia","year":"2014","journal-title":"J Proteome Res"},{"key":"50","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1158\/1078-0432.CCR-13-1939","article-title":"A distinct metabolic signature of human colorectal cancer with prognostic potential.","volume":"2","author":"Xu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"51","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1021\/ac300898h","article-title":"ADAP-GC 2.0: deconvolution of coeluting metabolites from GC\/TOF-MS data for metabolomics studies.","volume":"8","author":"Du","year":"2012","journal-title":"Anal Chem"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T18:08:19Z","timestamp":1599070099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,21]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6,30]]}},"alternative-id":["101487","29930218"],"URL":"https:\/\/doi.org\/10.18632\/aging.101487","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,21]]}}}